Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592084 · ClinicalTrials.gov registry record
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 267
- Enrollment target
NCT01592084 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 267 participants.
The verdict
NCT01592084 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 267 participants
- Enrollment target
Study Summary
The role of hyperlipidemia and lipid lowering therapy (LLT) in Amyotrophic Lateral Sclerosis (ALS) pathophysiology and its impact on disease progression and survival is unclear. The investigators analyzed the correlation between lipid levels with disease progression and survival in ALS patients and the association of LLT with these outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592084
The ClinicalTrials.gov registry entry for NCT01592084 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 267 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01592084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592084 about?
NCT01592084 is a clinical study titled "Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis". The role of hyperlipidemia and lipid lowering therapy (LLT) in Amyotrophic Lateral Sclerosis (ALS) pathophysiology and its impact on disease progression and survival is unclear. The investigators analyzed the correlation between lipid levels with disease progression and survival in ALS patients and ...
What is the current status of trial NCT01592084?
This trial is currently completed. The enrollment target is 267 participants. The study started on 2008-04. Estimated completion is 2011-09.
Who is sponsoring clinical trial NCT01592084?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.